Microsatellites’ Prognostic Role in Melanoma and Implications in the AJCC Classification System
Source: Physicians Weekly, March 2023
The following is a summary of “Prognostic role of microsatellites in melanoma and implications in the American Joint Committee on Cancer classification system: A cohort study,” published in the FEBRUARY 2023 issue of Dermatology by Loughlin, et al.
The results of microsatellite survival in melanoma patients need to be better understood. For a study, researchers sought to analyze sentinel lymph node biopsies in patients with microsatellites, their involvement in stage III of the American Joint Committee on Cancer classification, and survival outcomes in patients with microsatellites.
Patients with an invasive cutaneous melanoma diagnosis were enrolled in a retrospective bi-center cohort research from 1998 to 2019.